Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Stryker fractionally lower as investor day meeting continues » 15:15
11/18/21
11/18
15:15
11/18/21
15:15
SYK

Stryker

$262.20 /

+0.02 (+0.01%)

Stryker began its virtual…

Stryker began its virtual investor meeting at 2:30 pm and shares are down fractionally to $261.44 near 3:15 pm ET.

ShowHide Related Items >><<
SYK Stryker
$262.20 /

+0.02 (+0.01%)

SYK Stryker
$262.20 /

+0.02 (+0.01%)

10/29/21 Piper Sandler
Stryker price target lowered to $250 from $255 at Piper Sandler
09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
SYK Stryker
$262.20 /

+0.02 (+0.01%)

SYK Stryker
$262.20 /

+0.02 (+0.01%)

Conference/Events
Stryker to host virtual investor meeting » 14:25
11/18/21
11/18
14:25
11/18/21
14:25
SYK

Stryker

$261.72 /

-0.46 (-0.18%)

Virtual Investor Meeting…

Virtual Investor Meeting to be held on November 18 at 2:30 pm. Webcast Link

ShowHide Related Items >><<
SYK Stryker
$261.72 /

-0.46 (-0.18%)

SYK Stryker
$261.72 /

-0.46 (-0.18%)

10/29/21 Piper Sandler
Stryker price target lowered to $250 from $255 at Piper Sandler
09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
SYK Stryker
$261.72 /

-0.46 (-0.18%)

SYK Stryker
$261.72 /

-0.46 (-0.18%)

Conference/Events
Stryker to host virtual investor meeting » 04:55
11/18/21
11/18
04:55
11/18/21
04:55
SYK

Stryker

$262.05 /

-0.275 (-0.10%)

Virtual Investor Meeting…

Virtual Investor Meeting to be held on November 18 at 2:30 pm. Webcast Link

ShowHide Related Items >><<
SYK Stryker
$262.05 /

-0.275 (-0.10%)

SYK Stryker
$262.05 /

-0.275 (-0.10%)

10/29/21 Piper Sandler
Stryker price target lowered to $250 from $255 at Piper Sandler
09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
SYK Stryker
$262.05 /

-0.275 (-0.10%)

SYK Stryker
$262.05 /

-0.275 (-0.10%)

Conference/Events
Stryker to host virtual investor meeting » 17:16
11/17/21
11/17
17:16
11/17/21
17:16
SYK

Stryker

$262.05 /

-0.275 (-0.10%)

Virtual Investor Meeting…

Virtual Investor Meeting to be held on November 18 at 2:30 pm. Webcast Link

ShowHide Related Items >><<
SYK Stryker
$262.05 /

-0.275 (-0.10%)

SYK Stryker
$262.05 /

-0.275 (-0.10%)

10/29/21 Piper Sandler
Stryker price target lowered to $250 from $255 at Piper Sandler
09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
SYK Stryker
$262.05 /

-0.275 (-0.10%)

SYK Stryker
$262.05 /

-0.275 (-0.10%)

Over a month ago
Recommendations
Stryker price target lowered to $250 from $255 at Piper Sandler » 05:03
10/29/21
10/29
05:03
10/29/21
05:03
SYK

Stryker

$268.64 /

+0.21 (+0.08%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien lowered the firm's price target on Stryker to $250 from $255 and keeps a Neutral rating on the shares. The company reported Q3 results shy of the Street and lowered its outlook for Q4 to reflect increased Covid-19 headwinds, O'Brien tells investors in a research note. He believes the risk/reward for the shares is fairly balanced.

ShowHide Related Items >><<
SYK Stryker
$268.64 /

+0.21 (+0.08%)

SYK Stryker
$268.64 /

+0.21 (+0.08%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
SYK Stryker
$268.64 /

+0.21 (+0.08%)

SYK Stryker
$268.64 /

+0.21 (+0.08%)

On The Fly
Fly Intel: After-Hours Movers » 19:25
10/28/21
10/28
19:25
10/28/21
19:25
ATEN

A10 Networks

$13.82 /

+0.27 (+1.99%)

, TEAM

Atlassian

$417.02 /

+4.115 (+1.00%)

, X

U.S. Steel

$23.42 /

+0.08 (+0.34%)

, VCRA

Vocera

$50.47 /

+0.69 (+1.39%)

, AVT

Avnet

$37.31 /

+0.69 (+1.88%)

, NATI

National Instruments

$40.86 /

+0.58 (+1.44%)

, ACHC

Acadia Healthcare

$58.41 /

+2.28 (+4.06%)

, PTCT

PTC Therapeutics

$36.38 /

+0.93 (+2.62%)

, SKYW

SkyWest

$46.00 /

+0.6 (+1.32%)

, AVTR

Avantor

$38.30 /

+1.38 (+3.74%)

, HIG

Hartford Financial

$73.73 /

+0.92 (+1.26%)

, MVIS

MicroVision

$8.99 /

+0.725 (+8.77%)

, ZEN

Zendesk

$119.07 /

-3.64 (-2.97%)

, WDC

Western Digital

$57.34 /

+1.85 (+3.33%)

, FTDR

Frontdoor

$41.80 /

-0.48 (-1.14%)

, POWI

Power Integrations

$106.69 /

+7.48 (+7.54%)

, DVA

DaVita

$114.06 /

+3.11 (+2.80%)

, DAIO

Data I/O

$6.49 /

+0.01 (+0.15%)

, COHU

Cohu

$32.97 /

+2.3 (+7.50%)

, AMZN

Amazon.com

$3,447.14 /

+53.11 (+1.56%)

, SYK

Stryker

$268.64 /

+0.21 (+0.08%)

, AAPL

Apple

$152.48 /

+3.63 (+2.44%)

, SBUX

Starbucks

$113.09 /

-0.55 (-0.48%)

, TEX

Terex

$46.07 /

+2.37 (+5.42%)

, GILD

Gilead

$67.31 /

+0.51 (+0.76%)

, SKX

Skechers

$45.94 /

+1.16 (+2.59%)

ShowHide Related Items >><<
ZEN Zendesk
$119.07 /

-3.64 (-2.97%)

X U.S. Steel
$23.42 /

+0.08 (+0.34%)

WDC Western Digital
$57.34 /

+1.85 (+3.33%)

VCRA Vocera
$50.47 /

+0.69 (+1.39%)

TEX Terex
$46.07 /

+2.37 (+5.42%)

TEAM Atlassian
$417.02 /

+4.115 (+1.00%)

SYK Stryker
$268.64 /

+0.21 (+0.08%)

SKYW SkyWest
$46.00 /

+0.6 (+1.32%)

SKX Skechers
$45.94 /

+1.16 (+2.59%)

SBUX Starbucks
$113.09 /

-0.55 (-0.48%)

PTCT PTC Therapeutics
$36.38 /

+0.93 (+2.62%)

POWI Power Integrations
$106.69 /

+7.48 (+7.54%)

NATI National Instruments
$40.86 /

+0.58 (+1.44%)

MVIS MicroVision
$8.99 /

+0.725 (+8.77%)

HIG Hartford Financial
$73.73 /

+0.92 (+1.26%)

GILD Gilead
$67.31 /

+0.51 (+0.76%)

FTDR Frontdoor
$41.80 /

-0.48 (-1.14%)

DVA DaVita
$114.06 /

+3.11 (+2.80%)

COHU Cohu
$32.97 /

+2.3 (+7.50%)

AVTR Avantor
$38.30 /

+1.38 (+3.74%)

AVT Avnet
$37.31 /

+0.69 (+1.88%)

ATEN A10 Networks
$13.82 /

+0.27 (+1.99%)

AMZN Amazon.com
$3,447.14 /

+53.11 (+1.56%)

ACHC Acadia Healthcare
$58.41 /

+2.28 (+4.06%)

AAPL Apple
$152.48 /

+3.63 (+2.44%)

ATEN A10 Networks
$13.82 /

+0.27 (+1.99%)

07/28/21 BWS Financial
A10 Networks price target raised to $17 from $13.50 at BWS Financial
06/23/21 Craig-Hallum
A10 Networks initiated with a Buy at Craig-Hallum
06/23/21 Craig-Hallum
A10 Networks initiated with a Buy at Craig-Hallum
TEAM Atlassian
$417.02 /

+4.115 (+1.00%)

10/27/21 Wells Fargo
Atlassian price target raised to $475 from $325 at Wells Fargo
10/19/21 Cowen
Atlassian price target raised to $360 from $290 at Cowen
10/08/21 Mizuho
Mizuho raises Atlassian target to $440 after learning of price increases
09/24/21 Truist
Atlassian price target raised to $400 from $270 at Truist
X U.S. Steel
$23.42 /

+0.08 (+0.34%)

10/18/21 Morgan Stanley
U.S. Steel downgraded to Underweight from Overweight at Morgan Stanley
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 Argus
U.S. Steel upgraded to Buy from Hold at Argus
10/14/21 Argus
U.S. Steel upgraded to Buy from Hold at Argus
VCRA Vocera
$50.47 /

+0.69 (+1.39%)

10/26/21 BTIG
Vocera price target raised to $60 from $55 at BTIG
08/20/21 Piper Sandler
Vocera 'much more than a Covid play,' says Piper Sandler
08/19/21 BTIG
Vocera price target raised to $55 from $50 at BTIG
08/02/21 Piper Sandler
Vocera price target lowered to $53 from $56 at Piper Sandler
AVT Avnet
$37.31 /

+0.69 (+1.88%)

10/07/21 Truist
Avnet price target lowered to $40 from $45 at Truist
09/20/21 Longbow
Texas Instruments downgraded to Neutral from Buy at Longbow
04/30/21 Loop Capital
Avnet upgraded to Buy from Hold at Loop Capital
02/23/21 Citi
Citi opens long Arrow Electronics, short Avnet pair trade
NATI National Instruments
$40.86 /

+0.58 (+1.44%)

09/26/21 Goldman Sachs
National Instruments upgraded to Buy from Neutral at Goldman Sachs
01/08/21 Baird
National Instruments price target raised to $50 from $42 at Baird
ACHC Acadia Healthcare
$58.41 /

+2.28 (+4.06%)

09/27/21 SVB Leerink
Acadia Healthcare initiated with an Outperform at SVB Leerink
09/27/21 SVB Leerink
Acadia Healthcare initiated with an Outperform at SVB Leerink
09/23/21 UBS
Acadia Healthcare initiated with Buy, $81 target at UBS
09/23/21 UBS
Acadia Healthcare initiated with a Buy at UBS
PTCT PTC Therapeutics
$36.38 /

+0.93 (+2.62%)

10/18/21 BofA
PTC Therapeutics downgraded to Underperform from Neutral at BofA
10/18/21 BofA
PTC Therapeutics downgraded to Underperform from Neutral at BofA
08/31/21 UBS
PTC Therapeutics price target lowered to $45 from $55 at UBS
05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
SKYW SkyWest
$46.00 /

+0.6 (+1.32%)

04/21/21 Raymond James
SkyWest price target raised to $66 from $56 at Raymond James
03/16/21 Goldman Sachs
SkyWest price target raised to $70 from $51 at Goldman Sachs
02/22/21
Fly Intel: Top five analyst upgrades
02/22/21 Deutsche Bank
Deutsche upgrades eight airlines with Covid trending in right direction
AVTR Avantor
$38.30 /

+1.38 (+3.74%)

10/14/21 Cowen
Avantor price target lowered to $47 from $62 at Cowen
09/09/21 Evercore ISI
Avantor added to tactical outperform list at Evercore ISI
08/30/21 Raymond James
Avantor resumed with an Outperform at Raymond James
08/04/21 Credit Suisse
Avantor assumed with an Outperform at Credit Suisse
HIG Hartford Financial
$73.73 /

+0.92 (+1.26%)

10/15/21 Morgan Stanley
Hartford Financial resumed with an Equal Weight at Morgan Stanley
10/12/21 Barclays
Hartford Financial price target raised to $76 from $73 at Barclays
09/09/21 Credit Suisse
Hartford Financial price target raised to $93 from $82 at Credit Suisse
08/16/21 Wolfe Research
Hartford Financial initiated with a Peer Perform at Wolfe Research
MVIS MicroVision
$8.99 /

+0.725 (+8.77%)

ZEN Zendesk
$119.07 /

-3.64 (-2.97%)

10/20/21 Barclays
Zendesk initiated with an Overweight at Barclays
05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 UBS
Zendesk upgraded to Buy from Neutral at UBS
04/30/21 Piper Sandler
Zendesk price target raised to $186 from $180 at Piper Sandler
WDC Western Digital
$57.34 /

+1.85 (+3.33%)

10/19/21 Mizuho
Western Digital downgraded to Neutral from Buy at Mizuho
10/15/21
Fly Intel: Top five analyst downgrades
10/14/21 Goldman Sachs
Western Digital downgraded to Neutral from Buy at Goldman Sachs
10/12/21 Lynx
Lynx still bearish on Micron, would not be stepping in on long side
FTDR Frontdoor
$41.80 /

-0.48 (-1.14%)

04/19/21 Truist
Assurant price target raised to $185 from $170 at Truist
02/19/21 Truist
Frontdoor price target raised to $62 from $54 at Truist
12/16/20 JPMorgan
Frontdoor price target raised to $57 from $50 at JPMorgan
11/19/20 Oppenheimer
Frontdoor price target raised to $55 from $50 at Oppenheimer
POWI Power Integrations
$106.69 /

+7.48 (+7.54%)

08/26/21 Benchmark
Power Integrations price target raised to $130 from $115 at Benchmark
08/19/21
Fly Intel: Top five analyst initiations
08/19/21 Benchmark
Power Integrations initiated with a Buy at Benchmark
07/30/21 Northland
Power Integrations upgraded to Outperform from Market Perform at Northland
DVA DaVita
$114.06 /

+3.11 (+2.80%)

10/13/21 Truist
DaVita price target lowered to $125 from $145 at Truist
09/09/21 Cowen
DaVita business model needs to change, says Cowen
09/09/21 Cowen
DaVita initiated coverage with a Market Perform at Cowen
08/12/21 Barclays
DaVita assumed at Equal Weight from Overweight at Barclays
DAIO Data I/O
$6.49 /

+0.01 (+0.15%)

COHU Cohu
$32.97 /

+2.3 (+7.50%)

08/11/21 Goldman Sachs
Cohu downgraded to Sell from Neutral at Goldman Sachs
07/30/21 Craig-Hallum
Cohu price target lowered to $46 from $70 at Craig-Hallum
07/30/21 Needham
Cohu price target lowered to $45 from $55 at Needham
07/30/21 B. Riley
Cohu price target lowered to $52 from $65 at B. Riley
AMZN Amazon.com
$3,447.14 /

+53.11 (+1.56%)

10/25/21 Wedbush
E-commerce share gains, advertiser demand to drive Amazon Q3 beat, says Wedbush
10/22/21 Credit Suisse
Amazon price target lowered to $4,200 from $4,700 at Credit Suisse
10/21/21 Baird
Amazon executive commentary on supply chain 'largely positive,' says Baird
10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
SYK Stryker
$268.64 /

+0.21 (+0.08%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
AAPL Apple
$152.48 /

+3.63 (+2.44%)

10/28/21 Credit Suisse
Apple assumed with a Neutral at Credit Suisse
10/28/21 Wells Fargo
Twitter price target lowered to $70 from $82 at Wells Fargo
10/28/21 Cowen
Cowen upgrades Teradyne to Outperform after share underperformance
10/27/21 Wedbush
Twitter price target lowered to $69 from $76 at Wedbush
SBUX Starbucks
$113.09 /

-0.55 (-0.48%)

10/11/21
Fly Intel: Top five analyst upgrades
10/11/21 Deutsche Bank
Starbucks upgraded to Buy after recent pullback at Deutsche Bank
10/11/21 BofA
Starbucks reinstated with a Buy at BofA
10/11/21 Deutsche Bank
Starbucks upgraded to Buy from Hold at Deutsche Bank
TEX Terex
$46.07 /

+2.37 (+5.42%)

10/25/21 Deutsche Bank
Terex price target lowered to $51 from $55 at Deutsche Bank
10/14/21 Evercore ISI
Terex price target lowered to $67 from $74 at Evercore ISI
10/12/21 Citi
Terex price target lowered to $50 from $60 at Citi
08/30/21 Baird
Machinery stock pullback brings buying opportunities, says Baird
GILD Gilead
$67.31 /

+0.51 (+0.76%)

10/19/21 Cowen
Gilead assumed with an Outperform at Cowen
09/23/21 Citi
Citi opens 'Positive Catalyst Watch' on Merck into Covid data
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
SKX Skechers
$45.94 /

+1.16 (+2.59%)

10/19/21
Fly Intel: Top five analyst upgrades
10/19/21 Williams Capital
Skechers upgraded to Buy at Williams on 'supply chain prowess'
10/19/21 Williams Capital
Skechers upgraded to Buy from Hold at Williams Capital
10/18/21 Deutsche Bank
Skechers price target lowered to $58 from $64 at Deutsche Bank
ZEN Zendesk
$119.07 /

-3.64 (-2.97%)

X U.S. Steel
$23.42 /

+0.08 (+0.34%)

WDC Western Digital
$57.34 /

+1.85 (+3.33%)

VCRA Vocera
$50.47 /

+0.69 (+1.39%)

TEX Terex
$46.07 /

+2.37 (+5.42%)

TEAM Atlassian
$417.02 /

+4.115 (+1.00%)

SYK Stryker
$268.64 /

+0.21 (+0.08%)

SKYW SkyWest
$46.00 /

+0.6 (+1.32%)

SKX Skechers
$45.94 /

+1.16 (+2.59%)

SBUX Starbucks
$113.09 /

-0.55 (-0.48%)

PTCT PTC Therapeutics
$36.38 /

+0.93 (+2.62%)

POWI Power Integrations
$106.69 /

+7.48 (+7.54%)

NATI National Instruments
$40.86 /

+0.58 (+1.44%)

MVIS MicroVision
$8.99 /

+0.725 (+8.77%)

HIG Hartford Financial
$73.73 /

+0.92 (+1.26%)

GILD Gilead
$67.31 /

+0.51 (+0.76%)

FTDR Frontdoor
$41.80 /

-0.48 (-1.14%)

DVA DaVita
$114.06 /

+3.11 (+2.80%)

DAIO Data I/O
$6.49 /

+0.01 (+0.15%)

COHU Cohu
$32.97 /

+2.3 (+7.50%)

AVTR Avantor
$38.30 /

+1.38 (+3.74%)

AVT Avnet
$37.31 /

+0.69 (+1.88%)

ATEN A10 Networks
$13.82 /

+0.27 (+1.99%)

AMZN Amazon.com
$3,447.14 /

+53.11 (+1.56%)

ACHC Acadia Healthcare
$58.41 /

+2.28 (+4.06%)

AAPL Apple
$152.48 /

+3.63 (+2.44%)

  • 14
    Sep
  • 04
    Mar
  • 03
    Feb
  • 06
    Nov
X U.S. Steel
$23.42 /

+0.08 (+0.34%)

WDC Western Digital
$57.34 /

+1.85 (+3.33%)

TEX Terex
$46.07 /

+2.37 (+5.42%)

SBUX Starbucks
$113.09 /

-0.55 (-0.48%)

MVIS MicroVision
$8.99 /

+0.725 (+8.77%)

HIG Hartford Financial
$73.73 /

+0.92 (+1.26%)

GILD Gilead
$67.31 /

+0.51 (+0.76%)

FTDR Frontdoor
$41.80 /

-0.48 (-1.14%)

AMZN Amazon.com
$3,447.14 /

+53.11 (+1.56%)

AAPL Apple
$152.48 /

+3.63 (+2.44%)

X U.S. Steel
$23.42 /

+0.08 (+0.34%)

WDC Western Digital
$57.34 /

+1.85 (+3.33%)

TEAM Atlassian
$417.02 /

+4.115 (+1.00%)

SKX Skechers
$45.94 /

+1.16 (+2.59%)

SBUX Starbucks
$113.09 /

-0.55 (-0.48%)

NATI National Instruments
$40.86 /

+0.58 (+1.44%)

MVIS MicroVision
$8.99 /

+0.725 (+8.77%)

GILD Gilead
$67.31 /

+0.51 (+0.76%)

DVA DaVita
$114.06 /

+3.11 (+2.80%)

AVTR Avantor
$38.30 /

+1.38 (+3.74%)

AVT Avnet
$37.31 /

+0.69 (+1.88%)

ATEN A10 Networks
$13.82 /

+0.27 (+1.99%)

AMZN Amazon.com
$3,447.14 /

+53.11 (+1.56%)

AAPL Apple
$152.48 /

+3.63 (+2.44%)

X U.S. Steel
$23.42 /

+0.08 (+0.34%)

WDC Western Digital
$57.34 /

+1.85 (+3.33%)

TEAM Atlassian
$417.02 /

+4.115 (+1.00%)

SKX Skechers
$45.94 /

+1.16 (+2.59%)

SBUX Starbucks
$113.09 /

-0.55 (-0.48%)

MVIS MicroVision
$8.99 /

+0.725 (+8.77%)

HIG Hartford Financial
$73.73 /

+0.92 (+1.26%)

GILD Gilead
$67.31 /

+0.51 (+0.76%)

DVA DaVita
$114.06 /

+3.11 (+2.80%)

DAIO Data I/O
$6.49 /

+0.01 (+0.15%)

AMZN Amazon.com
$3,447.14 /

+53.11 (+1.56%)

AAPL Apple
$152.48 /

+3.63 (+2.44%)

AAPL Apple
$152.48 /

+3.63 (+2.44%)

Earnings
Stryker raises FY21 adjusted EPS view to $9.08-$9.15 from $8.80-$9.20 » 16:12
10/28/21
10/28
16:12
10/28/21
16:12
SYK

Stryker

$268.55 /

+0.12 (+0.04%)

Consensus $9.30. The…

Consensus $9.30. The company said, "We continue to monitor and evaluate the impact the global response to the COVID-19 pandemic has had, and will continue to have, on our operations and financial results. Based on third quarter performance, the volatility experienced as a result of COVID as well as the labor and staffing environment in healthcare potentially hindering an accelerated recovery, we now expect 2021 organic net sales growth to be in the range of 7% to 8% from 2019, and now expect adjusted net earnings per diluted share(2) to be in the range of $9.08 to $9.15, including the full year impact of the acquisition of Wright Medical. If foreign currency exchange rates hold near current levels, we expect EPS will be positively impacted by approximately $0.05 to $0.10 for the full year."

ShowHide Related Items >><<
SYK Stryker
$268.55 /

+0.12 (+0.04%)

SYK Stryker
$268.55 /

+0.12 (+0.04%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
SYK Stryker
$268.55 /

+0.12 (+0.04%)

Earnings
Stryker reports Q3 adjusted EPS $2.20, consensus $2.28 » 16:10
10/28/21
10/28
16:10
10/28/21
16:10
SYK

Stryker

$268.32 /

-0.11 (-0.04%)

Reports Q3 revenue…

Reports Q3 revenue $4.16B, consensus $4.23B. Q3 organic net sales increased 4.5%. "Our teams showed strong resilience and delivered solid quarterly financial results despite a resurgence of COVID-19 that intensified through the quarter," said Kevin Lobo, chair and CEO. "This latest spike mostly impacted our U.S. implant related businesses as scheduled procedures were deferred. Despite those impacts, we delivered strong growth in our MedSurg and NeuroTech businesses and are ready to support our customers as the pandemic recedes."

ShowHide Related Items >><<
SYK Stryker
$268.32 /

-0.11 (-0.04%)

SYK Stryker
$268.32 /

-0.11 (-0.04%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
SYK Stryker
$268.32 /

-0.11 (-0.04%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
ARAY

Accuray

$4.31 /

-0.08 (-1.82%)

, NVS

Novartis

$84.84 /

+1.49 (+1.79%)

, AZN

AstraZeneca

$62.29 /

+0.54 (+0.87%)

, BAYRY

Bayer

$14.20 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.76 /

-0.08 (-2.08%)

, BSX

Boston Scientific

$44.32 /

-0.17 (-0.38%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, EKTAY

Elekta

$11.58 /

+0.09 (+0.78%)

, GRTX

Galera Therapeutics

$1.88 /

+0.04 (+2.17%)

, DNA

Ginkgo Bioworks

$14.46 /

+0.19 (+1.33%)

, HTHIY

Hitachi

$118.77 /

-0.71 (-0.59%)

, MRK

Merck

$82.23 /

+0.545 (+0.67%)

, MYGN

Myriad Genetics

$30.66 /

-1.81 (-5.57%)

, NBTX

Nanobiotix

$12.35 /

-0.3 (-2.37%)

, NNOX

Nano-X Imaging

$22.54 /

-0.55 (-2.38%)

, NTRA

Natera

$115.95 /

+0.2 (+0.17%)

, NVCR

Novocure

$113.51 /

-5.91 (-4.95%)

, PHG

Philips

$47.69 /

-0.12 (-0.25%)

, REGN

Regeneron

$592.37 /

+16.45 (+2.86%)

, SNY

Sanofi

$49.98 /

+0.125 (+0.25%)

, SGEN

Seagen

$177.70 /

+2.29 (+1.31%)

, SMMNY

Siemens Healthineers

$34.66 /

-0.07 (-0.20%)

, SYK

Stryker

$273.25 /

+0.08 (+0.03%)

, TDY

Teledyne

$437.11 /

-7.89 (-1.77%)

, VRAY

ViewRay

$6.96 /

-0.05 (-0.71%)

, VREX

Varex Imaging

$26.36 /

-0.7 (-2.59%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

10/26/21 Lake Street
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.84 /

+1.49 (+1.79%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$82.23 /

+0.545 (+0.67%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.95 /

+0.2 (+0.17%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$113.51 /

-5.91 (-4.95%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.69 /

-0.12 (-0.25%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$592.37 /

+16.45 (+2.86%)

10/26/21 SVB Leerink
Regeneron price target raised to $798 from $785 at SVB Leerink
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$177.70 /

+2.29 (+1.31%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.25 /

+0.08 (+0.03%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$437.11 /

-7.89 (-1.77%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/26/21
10/26
04:55
10/26/21
04:55
ARAY

Accuray

$4.39 /

+0.02 (+0.46%)

, NVS

Novartis

$83.37 /

-1.515 (-1.78%)

, AZN

AstraZeneca

$61.75 /

-0.06 (-0.10%)

, BAYRY

Bayer

$14.16 /

+0.025 (+0.18%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.84 /

-0.02 (-0.52%)

, BSX

Boston Scientific

$44.49 /

-0.355 (-0.79%)

, BMY

Bristol-Myers

$57.84 /

+0.25 (+0.43%)

, EKTAY

Elekta

$11.49 /

-0.14 (-1.20%)

, GRTX

Galera Therapeutics

$1.84 /

+0.02 (+1.10%)

, DNA

Ginkgo Bioworks

$14.27 /

+1.145 (+8.72%)

, HTHIY

Hitachi

$119.48 /

+1.76 (+1.50%)

, MRK

Merck

$81.68 /

+0.52 (+0.64%)

, MYGN

Myriad Genetics

$32.47 /

+0.03 (+0.09%)

, NBTX

Nanobiotix

$12.35 /

-0.7 (-5.36%)

, NNOX

Nano-X Imaging

$23.08 /

+0.345 (+1.52%)

, NTRA

Natera

$115.78 /

+0.82 (+0.71%)

, NVCR

Novocure

$119.37 /

-1.5 (-1.24%)

, PHG

Philips

$47.81 /

-0.3 (-0.62%)

, REGN

Regeneron

$576.15 /

+3.42 (+0.60%)

, SNY

Sanofi

$49.85 /

+ (+0.00%)

, SGEN

Seagen

$175.45 /

+4.14 (+2.42%)

, SMMNY

Siemens Healthineers

$34.73 /

+0.342 (+0.99%)

, SYK

Stryker

$273.17 /

-2.71 (-0.98%)

, TDY

Teledyne

$444.97 /

-1.14 (-0.26%)

, VRAY

ViewRay

$7.01 /

+0.205 (+3.01%)

, VREX

Varex Imaging

$27.05 /

+0.12 (+0.45%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$83.37 /

-1.515 (-1.78%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.68 /

+0.52 (+0.64%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.78 /

+0.82 (+0.71%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$119.37 /

-1.5 (-1.24%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.81 /

-0.3 (-0.62%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$576.15 /

+3.42 (+0.60%)

10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
SNY Sanofi
$49.85 /

+ (+0.00%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$175.45 /

+4.14 (+2.42%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.17 /

-2.71 (-0.98%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$444.97 /

-1.14 (-0.26%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.85 /

+ (+0.00%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.